
“Charlie’s Law” Benefits Regenerative Medicine and Stem Cell Research in Texas
Director of Regenerative Medicine Research Doris Taylor, Ph.D., joined Texas lawmakers on a panel last week to discuss “Charlie’s Law,”...
Available in English and Spanish, this e-newsletter separates fact from fiction on over 40 heart topics by Texas Heart Medical Group's Dr. Stephanie Coulter.
Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Innovative Technologies & Techniques is produced at THI and explores promising advances in medicine that aim to extend the life of cardiac patients and patients at risk for series heart and vascular conditions. In response to the evolving pandemic, emerging topics related to COVID-19 are featured in the special Cardiology in the Time of COVID-19 episodes.
Our progress would not be possible without our donor community. Help support our mission by giving today.
Director of Regenerative Medicine Research Doris Taylor, Ph.D., joined Texas lawmakers on a panel last week to discuss “Charlie’s Law,”...
Houston, TX (September 15, 2017) – Texas Heart Institute kicked off the first day of its International Symposium on Cardiovascular Regenerative...
Study could lead to new treatments for a disease with limited options today Houston, TX (November 2, 2016) – Texas...
Stem Cell Tourism Near and Far: Achieving a Compromise for the Patient Houston, TX (September 22, 2016) – Patient advocacy groups...
Across the Texas Medical Center, scientists and physicians are leveraging stem cell and regenerative medicine research to usher in a...